{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:04:42Z","timestamp":1792789482938,"version":"4.5.0"},"reference-count":129,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Le Fonds Europ\u00e9en de D\u00e9veloppement R\u00e9gional (FEDER)"},{"name":"R\u00e9gion Grand Est, Mulhouse Alsace Agglom\u00e9ration and Fondation Lalance"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>To deliver the most effective cancer treatment, clinicians require rapid and accurate diagnoses that delineate tumor type, stage, and prognosis. Consequently, minimizing the need for repetitive and invasive procedures like biopsies and myelograms, along with their associated risks, is a critical challenge. Non-invasive monitoring offers a promising avenue for tumor detection, screening, and prognostication. While the identification of oncogenes and biomarkers from circulating tumor cells or tissue biopsies is currently standard practice for cancer diagnosis and classification, accumulating evidence underscores the significant role of epigenetics in regulating stem cell fate, including proliferation, self-renewal, and malignant transformation. This highlights the importance of analyzing the methylome, exosomes, and circulating RNA for detecting cellular transformation. The development of diagnostic assays that integrate liquid biopsies with epigenetic analysis holds immense potential for revolutionizing tumor management by enabling rapid, non-invasive diagnosis, real-time monitoring, and personalized treatment decisions. This review covers current studies exploring the use of epigenetic regulation, specifically the methylome and circulating RNA, as diagnostic tools derived from liquid biopsies. This approach shows promise in facilitating the differentiation between primary central nervous system lymphoma and other central nervous system tumors and may enable the detection and monitoring of acute myeloid\/lymphoid leukemia. We also discuss the current limitations hindering the rapid clinical translation of these technologies.<\/jats:p>","DOI":"10.3390\/ijms26157547","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T07:45:11Z","timestamp":1754466311000},"page":"7547","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Liquid Biopsy and Epigenetic Signatures in AML, ALL, and CNS Tumors: Diagnostic and Monitoring Perspectives"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7023-1723","authenticated-orcid":false,"given":"Anne","family":"Aries","sequence":"first","affiliation":[{"name":"Institut de Recherche en H\u00e9matologie et Transplantation (IRHT), H\u00f4pital du Hasenrain, 87 Avenue d\u2019Altkirch, 68100 Mulhouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2175-6785","authenticated-orcid":false,"given":"Bernard","family":"Dr\u00e9nou","sequence":"additional","affiliation":[{"name":"Institut de Recherche en H\u00e9matologie et Transplantation (IRHT), H\u00f4pital du Hasenrain, 87 Avenue d\u2019Altkirch, 68100 Mulhouse, France"},{"name":"Laboratoire d\u2019H\u00e9matologie, Groupe Hospitalier de la R\u00e9gion de Mulhouse Sud-Alsace, H\u00f4pital E. Muller, 20 Avenue de Dr. Laennec, 68100 Mulhouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2966-6386","authenticated-orcid":false,"given":"Rachid","family":"Lahlil","sequence":"additional","affiliation":[{"name":"Institut de Recherche en H\u00e9matologie et Transplantation (IRHT), H\u00f4pital du Hasenrain, 87 Avenue d\u2019Altkirch, 68100 Mulhouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0065-2423(10)52006-7","article-title":"Methylation of DNA in Cancer","volume":"Volume 52","author":"Watanabe","year":"2010","journal-title":"Advances in Clinical Chemistry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2022.10.015","article-title":"Methylation Biomarkers for Early Cancer Detection and Diagnosis: Current and Future Perspectives","volume":"178","author":"Ibrahim","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1308309","DOI":"10.3389\/fphar.2024.1308309","article-title":"Research Progress and Applications of Epigenetic Biomarkers in Cancer","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40478-022-01371-2","article-title":"DNA Methylation as a Diagnostic Tool","volume":"10","author":"Galbraith","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Nejati-Koshki, K., Roberts, C.-T., Babaei, G., and Rastegar, M. (2023). The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology. Cancers, 15.","DOI":"10.3390\/cancers15102683"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1038\/s41467-023-41774-w","article-title":"Multimodal Analysis of Cell-Free DNA Whole-Methylome Sequencing for Cancer Detection and Localization","volume":"14","author":"Bie","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41568-025-00795-x","article-title":"Genomic and Fragmentomic Landscapes of Cell-Free DNA for Early Cancer Detection","volume":"25","author":"Bruhm","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a Molecular Understanding of microRNA-Mediated Gene Silencing","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/cr.2015.82","article-title":"Circular RNA Is Enriched and Stable in Exosomes: A Promising Biomarker for Cancer Diagnosis","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"D106","DOI":"10.1093\/nar\/gkx891","article-title":"exoRBase: A Database of circRNA, lncRNA and mRNA in Human Blood Exosomes","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11910-024-01389-0","article-title":"Advances in Primary Central Nervous System Lymphoma","volume":"25","author":"Therkelsen","year":"2024","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nrclinonc.2016.204","article-title":"Advances in the Molecular Genetics of Gliomas\u2014Implications for Classification and Therapy","volume":"14","author":"Reifenberger","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA Methylation-Based Classification of Central Nervous System Tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12935-023-03074-7","article-title":"Methylomics and Cancer: The Current State of Methylation Profiling and Marker Development for Clinical Care","volume":"23","author":"Liu","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem Cells, Cancer, and Cancer Stem Cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network (2013). Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia. N. Engl. J. Med., 368, 2059\u20132074.","DOI":"10.1056\/NEJMoa1301689"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41588-018-0270-1","article-title":"Subtype-Specific Regulatory Network Rewiring in Acute Myeloid Leukemia","volume":"51","author":"Assi","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from Committed Progenitor to Leukaemia Stem Cell Initiated by MLL\u2013AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood-2016-01-693879","article-title":"Spectrum and Prognostic Relevance of Driver Gene Mutations in Acute Myeloid Leukemia","volume":"128","author":"Metzeler","year":"2016","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"149ra118","DOI":"10.1126\/scitranslmed.3004315","article-title":"Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia","volume":"4","author":"Jan","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.18632\/oncotarget.23575","article-title":"Assessment of a New Genomic Classification System in Acute Myeloid Leukemia with a Normal Karyotype","volume":"9","author":"Ahn","year":"2017","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1442539","DOI":"10.3389\/fgene.2024.1442539","article-title":"Multi-Omic Analysis of Longitudinal Acute Myeloid Leukemia Patient Samples Reveals Potential Prognostic Markers Linked to Disease Progression","volume":"15","author":"Ahmed","year":"2024","journal-title":"Front. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41467-024-55691-z","article-title":"Increased Local DNA Methylation Disorder in AMLs with DNMT3A-Destabilizing Variants and Its Clinical Implication","volume":"16","author":"Lee","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"108396","DOI":"10.1016\/j.compbiomed.2024.108396","article-title":"Unlocking the Potential: A Novel Prognostic Index Signature for Acute Myeloid Leukemia","volume":"173","author":"Zhang","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1002\/cam4.3291","article-title":"Genome-Wide DNA Methylome Analysis Reveals Methylation Subtypes with Different Clinical Outcomes for Acute Myeloid Leukemia Patients","volume":"9","author":"Gao","year":"2020","journal-title":"Cancer Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e2300265","DOI":"10.1200\/CCI.23.00265","article-title":"Identification of Novel DNA Methylation Prognostic Biomarkers for AML With Normal Cytogenetics","volume":"8","author":"Cardoso","year":"2024","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100965","DOI":"10.1016\/j.neo.2024.100965","article-title":"DNA Methylation Landscape Reveals GNAS as a Decitabine-Responsive Marker in Patients with Acute Myeloid Leukemia","volume":"49","author":"He","year":"2024","journal-title":"Neoplasia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2217\/epi-2023-0406","article-title":"Digital PCR-Based GRHL2 Methylation Testing in Acute Myeloid Leukemia: Diagnosis, Prognosis and Monitoring","volume":"16","author":"Hua","year":"2024","journal-title":"Epigenomics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12885-025-13633-y","article-title":"Identification of HOXA9 Methylation as an Epigenetic Biomarker Predicting Prognosis and Guiding Treatment Choice in Acute Myeloid Leukemia","volume":"25","author":"Xie","year":"2025","journal-title":"BMC Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13148-025-01823-1","article-title":"miR-182 Promoter Hypermethylation Predicts the Better Outcome of AML Patients Treated with AZA\u2009+\u2009VEN in a Real-World Setting","volume":"17","author":"Xu","year":"2025","journal-title":"Clin. Epigenetics"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13148-023-01580-z","article-title":"Predictive Value of DNA Methylation Patterns in AML Patients Treated with an Azacytidine Containing Induction Regimen","volume":"15","author":"Schmutz","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s10238-022-00980-4","article-title":"DNA Methylation-Based Subtypes of Acute Myeloid Leukemia with Distinct Prognosis and Clinical Features","volume":"23","author":"Jian","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s13353-024-00881-0","article-title":"Identifying Key Genes and Functionally Enriched Pathways in Acute Myeloid Leukemia by Weighted Gene Co-Expression Network Analysis","volume":"66","author":"Jian","year":"2024","journal-title":"J. Appl. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/CAD.0000000000001688","article-title":"Comprehensive Analysis of DNA Methylation and Gene Expression to Identify Tumor Suppressor Genes Reactivated by MLN4924 in Acute Myeloid Leukemia","volume":"36","author":"Guo","year":"2025","journal-title":"Anticancer Drugs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/1878-0261.70000","article-title":"Classification of Acute Myeloid Leukemia Based on Multi-Omics and Prognosis Prediction Value","volume":"19","author":"Song","year":"2025","journal-title":"Mol. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1490330","DOI":"10.3389\/fimmu.2025.1490330","article-title":"Hypomethylation of GCNT2 Isoform A Correlates with Transcriptional Expression and Is Associated with Poor Survival in Acute Myeloid Leukemia","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15815","DOI":"10.1038\/s41598-025-99258-4","article-title":"Machine Learning Approaches Reveal Methylation Signatures Associated with Pediatric Acute Myeloid Leukemia Recurrence","volume":"15","author":"Dong","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project (1993). A Predictive Model for Aggressive Non-Hodgkin\u2019s Lymphoma. N. Engl. J. Med., 329, 987\u2013994.","DOI":"10.1056\/NEJM199309303291402"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-cancerbio-043020-110055","article-title":"Molecular Biology of Childhood Leukemia","volume":"5","author":"Alexander","year":"2021","journal-title":"Annu. Rev. Cancer Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s43018-022-00370-5","article-title":"Acute Lymphoblastic Leukemia Displays a Distinct Highly Methylated Genome","volume":"3","author":"Hetzel","year":"2022","journal-title":"Nat. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2009-04-214668","article-title":"DNA Methylation for Subtype Classification and Prediction of Treatment Outcome in Patients with Childhood Acute Lymphoblastic Leukemia","volume":"115","author":"Milani","year":"2010","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/path.6346","article-title":"DNA Methylation as a New Tool for the Differential Diagnosis between T-LBL and Lymphocyte-Rich Thymoma","volume":"264","author":"Latiri","year":"2024","journal-title":"J. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ajh.27533","article-title":"Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical Pilot","volume":"100","author":"Witzig","year":"2025","journal-title":"Am. J. Hematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1158\/1078-0432.CCR-05-2592","article-title":"CpG Island Methylator Phenotype Redefines the Prognostic Effect of t(12;21) in Childhood Acute Lymphoblastic Leukemia","volume":"12","author":"Agirre","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1182\/blood.2024026027","article-title":"CpG Island Methylator Phenotype Classification Improves Risk Assessment in Pediatric T-Cell Acute Lymphoblastic Leukemia","volume":"145","author":"Refhagen","year":"2025","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1038\/s41467-024-49811-y","article-title":"Epigenetic Alterations Affecting Hematopoietic Regulatory Networks as Drivers of Mixed Myeloid\/Lymphoid Leukemia","volume":"15","author":"Nuetzel","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12943-024-02118-4","article-title":"Epigenome-Wide Analysis across the Development Span of Pediatric Acute Lymphoblastic Leukemia: Backtracking to Birth","volume":"23","author":"Ghantous","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"D1380","DOI":"10.1093\/nar\/gkad923","article-title":"MethMarkerDB: A Comprehensive Cancer DNA Methylation Biomarker Database","volume":"52","author":"Zhu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/CCO.0000000000001079","article-title":"Liquid Biopsy in Brain Tumors: Moving on, Slowly","volume":"36","author":"Berzero","year":"2024","journal-title":"Curr. Opin. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/neuonc\/noac264","article-title":"Cerebrospinal Fluid Methylome-Based Liquid Biopsies for Accurate Malignant Brain Neoplasm Classification","volume":"25","author":"Zuccato","year":"2023","journal-title":"Neuro Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13148-021-01091-9","article-title":"Methylated Markers Accurately Distinguish Primary Central Nervous System Lymphomas (PCNSL) from Other CNS Tumors","volume":"13","author":"Downs","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40478-019-0668-8","article-title":"Methylation Array Profiling of Adult Brain Tumours: Diagnostic Outcomes in a Large, Single Centre","volume":"7","author":"Jaunmuktane","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41591-024-03286-y","article-title":"Prediction of Brain Metastasis Development with DNA Methylation Signatures","volume":"31","author":"Zuccato","year":"2024","journal-title":"Nat. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/neuonc\/noae214","article-title":"Longitudinal Multimodal Profiling of IDH-Wildtype Glioblastoma Reveals the Molecular Evolution and Cellular Phenotypes Underlying Prognostically Different Treatment Responses","volume":"27","author":"Lucas","year":"2024","journal-title":"Neuro Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1038\/s41467-023-41434-z","article-title":"Detection of Diagnostic and Prognostic Methylation-Based Signatures in Liquid Biopsy Specimens from Patients with Meningiomas","volume":"14","author":"Herrgott","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00401-025-02849-8","article-title":"IDH-Mutant Astrocytomas with Primitive Neuronal Component Have a Distinct Methylation Profile and a Higher Risk of Leptomeningeal Spread","volume":"149","author":"Hinz","year":"2025","journal-title":"Acta Neuropathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1038\/s41598-025-90658-0","article-title":"Multi-Omics Analysis Identifies Novels Genes Involved in Glioma Prognosis","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41597-025-04597-6","article-title":"Transcriptomics and Epigenomics Datasets of Primary Brain Cancers in Formalin-Fixed Paraffin Embedded Format","volume":"12","author":"Rojas","year":"2025","journal-title":"Sci. Data"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00415-025-12923-6","article-title":"Clinical Characteristics, Molecular Reclassification Trajectories and DNA Methylation Patterns of Long- and Short-Term Survivors of WHO Grade II and III Glioma","volume":"272","author":"Mair","year":"2025","journal-title":"J. Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"27545","DOI":"10.1038\/s41598-024-79391-2","article-title":"Discovery of Key Molecular Signatures for Diagnosis and Therapies of Glioblastoma by Combining Supervised and Unsupervised Learning Approaches","volume":"14","author":"Sarker","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cdd.2014.130","article-title":"Exosomes as Divine Messengers: Are They the Hermes of Modern Molecular Oncology?","volume":"22","author":"Braicu","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications","volume":"15","author":"Zhang","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Goenka, A., Tiek, D.M., Song, X., Iglesia, R.P., Lu, M., Hu, B., and Cheng, S.-Y. (2022). The Role of Non-Coding RNAs in Glioma. Biomedicines, 10.","DOI":"10.3390\/biomedicines10082031"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12868-022-00736-6","article-title":"A Circular RNA Derived from GLIS3 Accelerates the Proliferation of Glioblastoma Cells through Competitively Binding with miR-449c-5p to Upregulate CAPG and GLIS3","volume":"23","author":"Zhou","year":"2022","journal-title":"BMC Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"eabc0221","DOI":"10.1126\/sciadv.abc0221","article-title":"The Nuclear DICER-Circular RNA Complex Drives the Deregulation of the Glioblastoma Cell microRNAome","volume":"6","author":"Bronisz","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41556-021-00639-4","article-title":"Circular RNA-Encoded Oncogenic E-Cadherin Variant Promotes Glioblastoma Tumorigenicity through Activation of EGFR-STAT3 Signalling","volume":"23","author":"Gao","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Merulla, A.E., Stella, M., Barbagallo, C., Battaglia, R., Caponnetto, A., Broggi, G., Altieri, R., Certo, F., Caltabiano, R., and Ragusa, M. (2022). circSMARCA5 Is an Upstream Regulator of the Expression of miR-126-3p, miR-515-5p, and Their mRNA Targets, Insulin-like Growth Factor Binding Protein 2 (IGFBP2) and NRAS Proto-Oncogene, GTPase (NRAS) in Glioblastoma. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213676"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Beylerli, O., Encarnacion Ramirez, M.d.J., Shumadalova, A., Ilyasova, T., Zemlyanskiy, M., Beilerli, A., and Montemurro, N. (2023). Cell-Free miRNAs as Non-Invasive Biomarkers in Brain Tumors. Diagnostics, 13.","DOI":"10.3390\/diagnostics13182888"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12935-015-0185-1","article-title":"MicroRNA (miRNA) in Cancer","volume":"15","author":"Reddy","year":"2015","journal-title":"Cancer Cell Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"598817","DOI":"10.3389\/fonc.2020.598817","article-title":"Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers","volume":"10","author":"Gao","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1002\/iid3.725","article-title":"Emerging Roles of circRNAs in Leukemia and the Clinical Prospects: An Update","volume":"11","author":"Deng","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The Biogenesis, Biology and Characterization of Circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-020-01175-9","article-title":"Role of Non-Coding RNA Networks in Leukemia Progression, Metastasis and Drug Resistance","volume":"19","author":"Bhat","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.1038\/srep11295","article-title":"Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML","volume":"5","author":"Hornick","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12032-024-02547-7","article-title":"Dual Roles of Extracellular Vesicles in Acute Lymphoblastic Leukemia: Implications for Disease Progression and Theranostic Strategies","volume":"42","author":"Lajevardi","year":"2024","journal-title":"Med. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/CBM-210360","article-title":"miR-370 Is Better than miR-375 as a Non-Invasive Diagnostic Biomarker for Pediatric Acute Myeloid Leukemia Patients","volume":"34","author":"Ali","year":"2022","journal-title":"Cancer Biomark."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.7150\/thno.80054","article-title":"Human Circulating Small Non-Coding RNA Signature as a Non-Invasive Biomarker in Clinical Diagnosis of Acute Myeloid Leukaemia","volume":"13","author":"Xia","year":"2023","journal-title":"Theranostics"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13148-024-01658-2","article-title":"Low Expression of miR-182 Caused by DNA Hypermethylation Accelerates Acute Lymphocyte Leukemia Development by Targeting PBX3 and BCL2: miR-182 Promoter Methylation Is a Predictive Marker for Hypomethylation Agents\u2009+\u2009BCL2 Inhibitor Venetoclax","volume":"16","author":"Li","year":"2024","journal-title":"Clin. Epigenetics"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7150\/thno.77404","article-title":"DNA Hypermethylation-Induced miR-182 Silence Targets BCL2 and HOXA9 to Facilitate the Self-Renewal of Leukemia Stem Cell, Accelerate Acute Myeloid Leukemia Progression, and Determine the Sensitivity of BCL2 Inhibitor Venetoclax","volume":"13","author":"Ye","year":"2023","journal-title":"Theranostics"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"102240","DOI":"10.1016\/j.trim.2025.102240","article-title":"Plasma-Circulating miR-638, miR-6511b-5p, miR-3613-5p, miR-455-3p, miR-5787, and miR-548a-3p as Noninvasive Biomarkers of Immune Reconstitution Post-Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients","volume":"91","author":"Izadifard","year":"2025","journal-title":"Transplant Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40164-016-0059-9","article-title":"Long Noncoding RNAs: Pivotal Regulators in Acute Myeloid Leukemia","volume":"5","author":"Wei","year":"2016","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1007\/s00277-024-05987-3","article-title":"The Role of Long Noncoding RNAs in the Diagnosis, Prognosis and Therapeutic Biomarkers of Acute Myeloid Leukemia","volume":"103","author":"Atnaf","year":"2024","journal-title":"Ann. Hematol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e7376","DOI":"10.1002\/cam4.7376","article-title":"Long Non-Coding RNA as Potential Diagnostic Markers for Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis","volume":"13","author":"Solomon","year":"2024","journal-title":"Cancer Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1038\/s41598-022-08930-6","article-title":"Revealing Key lncRNAs in Cytogenetically Normal Acute Myeloid Leukemia by Reconstruction of the lncRNA\u2013miRNA\u2013mRNA Network","volume":"12","author":"Sun","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s43042-021-00147-y","article-title":"HOTAIR Expression and Prognostic Impact in Acute Myeloid Leukemia Patients","volume":"22","author":"Saad","year":"2021","journal-title":"Egypt. J. Med. Human Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"8223216","DOI":"10.1155\/2021\/8223216","article-title":"Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia","volume":"2021","author":"Liu","year":"2021","journal-title":"Dis. Markers"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1182\/bloodadvances.2024012667","article-title":"A 69 Long Noncoding RNA Signature Predicts Relapse and Acts as Independent Prognostic Factor in Pediatric AML","volume":"8","author":"Ren","year":"2024","journal-title":"Blood Adv."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"216880","DOI":"10.1016\/j.canlet.2024.216880","article-title":"circRNAs as Prognostic Markers in Pediatric Acute Myeloid Leukemia","volume":"591","author":"Sun","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"22783","DOI":"10.1038\/s41598-021-02257-4","article-title":"Circulating miR-146a Expression as a Non-Invasive Predictive Biomarker for Acute Lymphoblastic Leukemia","volume":"11","author":"Shahid","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"101893","DOI":"10.1016\/j.mcp.2023.101893","article-title":"MiR-128-3p as Blood Based Liquid Biopsy Biomarker in Childhood Acute Lymphoblastic Leukemia","volume":"67","author":"Rzepiel","year":"2023","journal-title":"Mol. Cell Probes"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s12967-021-03174-w","article-title":"Extracellular Vesicles Carrying miRNA-181b-5p Affects the Malignant Progression of Acute Lymphoblastic Leukemia","volume":"19","author":"Yan","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41598-023-50628-w","article-title":"Plasma-Derived Exosomal miR-326, a Prognostic Biomarker and Novel Candidate for Treatment of Drug Resistant Pediatric Acute Lymphoblastic Leukemia","volume":"14","author":"Saffari","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3892\/ol.2023.14204","article-title":"miRNAs as Predictive Biomarkers of Response to Treatment in Pediatric Patients with Acute Lymphoblastic Leukemia","volume":"27","author":"Tsotridou","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40364-021-00303-x","article-title":"LncRNAs Serve as Novel Biomarkers for Diagnosis and Prognosis of Childhood ALL","volume":"9","author":"Huang","year":"2021","journal-title":"Biomark. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-022-01514-y","article-title":"CircPVT1: A Pivotal Circular Node Intersecting Long Non-Coding-PVT1 and c-MYC Oncogenic Signals","volume":"21","author":"Palcau","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12935-021-01956-2","article-title":"Biogenesis, Cellular Effects, and Biomarker Value of circHIPK3","volume":"21","author":"Fu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/16078454.2021.1997197","article-title":"Circ_0000745 Regulates NOTCH1-Mediated Cell Proliferation and Apoptosis in Pediatric T-Cell Acute Lymphoblastic Leukemia through Adsorbing miR-193b-3p","volume":"26","author":"Feng","year":"2021","journal-title":"Hematology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1182\/bloodadvances.2020002337","article-title":"Large-Scale Circular RNA Deregulation in T-ALL: Unlocking Unique Ectopic Expression of Molecular Subtypes","volume":"4","author":"Buratin","year":"2020","journal-title":"Blood Adv."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"116903","DOI":"10.1016\/j.biopha.2024.116903","article-title":"Identification of a Circular RNA Isoform of WASHC2A as a Prognostic Factor for High-Risk Paediatric B-ALL Patients","volume":"177","author":"Filomena","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Gutierrez-Camino, A., Caron, M., Richer, C., Fuchs, C., Illarregi, U., Poncelet, L., St-Onge, P., Bataille, A.R., Tremblay-Dauphinais, P., and Lopez-Lopez, E. (2024). CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031477"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1357321","DOI":"10.3389\/fneur.2024.1357321","article-title":"MicroRNA as a Potential Diagnostic and Prognostic Biomarker in Brain Gliomas: A Systematic Review and Meta-Analysis","volume":"15","author":"Hasani","year":"2024","journal-title":"Front. Neurol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"vdad063","DOI":"10.1093\/noajnl\/vdad063","article-title":"Diagnostic and Therapeutic Potential of Circular RNA in Brain Tumors","volume":"5","author":"Katsushima","year":"2023","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/neuonc\/nor169","article-title":"Identification of microRNAs in the Cerebrospinal Fluid as Biomarker for the Diagnosis of Glioma","volume":"14","author":"Baraniskin","year":"2012","journal-title":"Neuro Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11060-018-2749-0","article-title":"MicroRNA-30c as a Novel Diagnostic Biomarker for Primary and Secondary B-Cell Lymphoma of the CNS","volume":"137","author":"Baraniskin","year":"2018","journal-title":"J. Neurooncol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Sromek, M., Rymkiewicz, G., Paziewska, A., Szafron, L.M., Kulecka, M., Zajdel, M., Kulinczak, M., Dabrowska, M., Balabas, A., and Bystydzienski, Z. (2021). A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors. Biomolecules, 11.","DOI":"10.3390\/biom11091395"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e0312250","DOI":"10.1371\/journal.pone.0312250","article-title":"The Significance of miR-124 in the Diagnosis and Prognosis of Glioma: A Systematic Review","volume":"19","author":"Ghasemi","year":"2024","journal-title":"PLoS ONE"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s11658-022-00354-4","article-title":"Recent Insights into the microRNA-Dependent Modulation of Gliomas from Pathogenesis to Diagnosis and Treatment","volume":"27","author":"Mafi","year":"2022","journal-title":"Cell Mol. Biol. Lett."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s41598-024-83800-x","article-title":"Expression of Some Circulating microRNAs as Predictive Biomarkers for Prognosis and Treatment Response in Glioblastoma","volume":"15","author":"Ali","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41374-021-00720-4","article-title":"Cell-Free Plasma microRNAs That Identify Patients with Glioblastoma","volume":"102","author":"Bustos","year":"2022","journal-title":"Lab. Investig."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Pei, D., Zhang, D., Guo, Y., Chang, H., and Cui, H. (2025). Long Non-Coding RNAs in Malignant Human Brain Tumors: Driving Forces Behind Progression and Therapy. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020694"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41598-024-82109-z","article-title":"Super-Enhancer-Driven SLCO4A1-AS1 Is a New Biomarker and a Promising Therapeutic Target in Glioblastoma","volume":"15","author":"Wu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e0314618","DOI":"10.1371\/journal.pone.0314618","article-title":"ZNF503-AS2 Is a Promising Therapeutic Target and Is Associated with the Immune Microenvironment in Glioma","volume":"19","author":"Wu","year":"2024","journal-title":"PLoS ONE"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11060-022-04030-7","article-title":"Prognostic Utility of lncRNAs (LINC00565 and LINC00641) as Molecular Markers in Glioblastoma Multiforme (GBM)","volume":"158","author":"Amer","year":"2022","journal-title":"J. Neurooncol"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"102774","DOI":"10.1016\/j.ctrv.2024.102774","article-title":"Liquid Biopsy: An Arsenal for Tumour Screening and Early Diagnosis","volume":"129","author":"Zhang","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.bbrc.2018.07.081","article-title":"CircRNA circHIPK3 Serves as a Prognostic Marker to Promote Glioma Progression by Regulating miR-654\/IGF2BP3 Signaling","volume":"503","author":"Jin","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Stella, M., Falzone, L., Caponnetto, A., Gattuso, G., Barbagallo, C., Battaglia, R., Mirabella, F., Broggi, G., Altieri, R., and Certo, F. (2021). Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme. Pharmaceuticals, 14.","DOI":"10.3390\/ph14070618"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/jnci\/djx166","article-title":"Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis","volume":"110","author":"Yang","year":"2018","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2014.222679","article-title":"Circulating Tumor DNA as a Liquid Biopsy for Cancer","volume":"61","author":"Heitzer","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40478-019-0692-8","article-title":"Tumor Cell-Free DNA Detection in CSF for Primary CNS Lymphoma Diagnosis","volume":"7","author":"Rimelen","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/blood-2015-01-620518","article-title":"High Frequency of MYD88 Mutations in Vitreoretinal B-Cell Lymphoma: A Valuable Tool to Improve Diagnostic Yield of Vitreous Aspirates","volume":"126","author":"Bonzheim","year":"2015","journal-title":"Blood"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Bunda, S., Zuccato, J.A., Voisin, M.R., Wang, J.Z., Nassiri, F., Patil, V., Mansouri, S., and Zadeh, G. (2021). Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094548"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"104504","DOI":"10.1016\/j.critrevonc.2024.104504","article-title":"The Potential of Circulating Cell-Free RNA in CNS Tumor Diagnosis and Monitoring: A Liquid Biopsy Approach","volume":"204","author":"Aran","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_123","first-page":"925","article-title":"\u00c9pig\u00e9n\u00e9tique et cancer: La m\u00e9thylation dans tous ses \u00e9tats","volume":"40","author":"Gorse","year":"2024","journal-title":"Med. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-024-01728-9","article-title":"Unclassifiable CNS Tumors in DNA Methylation-Based Classification: Clinical Challenges and Prognostic Impact","volume":"12","author":"Drexler","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"vdad115","DOI":"10.1093\/noajnl\/vdad115","article-title":"Quantitative Analysis of MGMT Promoter Methylation in Glioblastoma Suggests Nonlinear Prognostic Effect","volume":"5","author":"Gibson","year":"2023","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/PO.20.00016","article-title":"Systematic Assessment of Tumor Purity and Its Clinical Implications","volume":"4","author":"Haider","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1208\/s12248-025-01038-5","article-title":"From Guidelines to Implementation: A Case Study on Applying ICH M10 for Bioanalytical Assay Cross-Validation","volume":"27","author":"Gu","year":"2025","journal-title":"AAPS J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e029574","DOI":"10.1161\/JAHA.123.029574","article-title":"Circulating Cardiovascular Biomarkers in Cancer Therapeutics-Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions","volume":"12","author":"Murtagh","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_129","first-page":"1000005","article-title":"Overcoming Challenges in Biomarker Translation a Pathway to Clinical Implementation","volume":"14","author":"Hoppe","year":"2024","journal-title":"J. Clin. Trials"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7547\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:23:18Z","timestamp":1760034198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":129,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157547"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157547","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]}}}